| The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose … MV Mattoli, M Massaccesi, A Castelluccia, V Scolozzi, G Mantini, ... Radiation Oncology 12, 1-11, 2017 | 25 | 2017 |
| Economic evaluations of magnetic resonance image-guided radiotherapy (MRIgRT): A systematic review A Castelluccia, P Mincarone, MR Tumolo, S Sabina, R Colella, A Bodini, ... International Journal of Environmental Research and Public Health 19 (17), 10800, 2022 | 5 | 2022 |
| Magnetic resonance guided SBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis L Boldrini, A Romano, G Chiloiro, S Corradini, V De Luca, V Verusio, ... Radiation Oncology 18 (1), 84, 2023 | 4 | 2023 |
| Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases G Ugurluer, FL Schneiders, S Corradini, L Boldrini, R Kotecha, P Kelly, ... Clinical and Translational Radiation Oncology 46, 100756, 2024 | 1 | 2024 |
| PO-0679: Radiation-induced lung injury (RILI): correlation with dosimetric parameters and pulmonary function GR D'Agostino, F De Rose, M Balducci, F Micciché, AR Larici, SI Santoro, ... Radiotherapy and Oncology 106, S261, 2013 | 1 | 2013 |
| 10-yr Results of Moderately Hypofractionated Postoperative Radiotherapy for Prostate Cancer Focused on Treatment Related Toxicity A Castelluccia, F Tramacere, RR Colciago, M Borgia, A Sallustio, T Proto, ... Clinical Genitourinary Cancer 22 (4), 102102, 2024 | | 2024 |
| 3137: RADIOABLATION FOR VENTRICULAR TACHYCARDIA: A COHORT MULTICENTER ANALYSIS OF EFFICACY AND HOMOGENEITY F Cellini, ML Narducci, P Gentile, MF Osti, A Fiorentino, AG Morganti, ... Radiotherapy and Oncology 194, S2012-S2013, 2024 | | 2024 |
| 771: Hypofractionated dose-escalated salvage RT for macroscopic prostate cancer local recurrence A Castelluccia, F Tramacere, M Borgia, M Portaluri Radiotherapy and Oncology 194, S2351-S2352, 2024 | | 2024 |
| 1566: Intensification of RT dose, rather than, chemotherapy, in Total Neoadjuvant Therapy for rectal cancer A Castelluccia, G Grimaldi, D Marchesano, F Bianciardi, A Di Palma, ... Radiotherapy and Oncology 194, S1517-S1519, 2024 | | 2024 |
| 3171: Breast Cancer Radiotherapy after Neoadjuvant Systemic Therapy: a retrospective evaluation MC De Luca, R Castagna, MC Francavilla, T Proto, A Castelluccia, ... Radiotherapy and Oncology 194, S720-S722, 2024 | | 2024 |
| Durable complete response to PET‐CT driven stereotactic radiation therapy plus pembrolizumab for pleomorphic Pancoast cancer: Case report and literature review A Castelluccia, A Sardaro, AN Asabella, AR Pisani, D Rubini, M Portaluri, ... Clinical Case Reports 12 (4), 2024 | | 2024 |
| Role of 18 F-FCH PET/CT in Detecting Recurrences of Prostate Cancer After Curative Treatments. C Altini, AN Asabella, F Tramacere, A Sardaro, AR Pisani, A Castelluccia, ... Molecular Imaging and Radionuclide Therapy 33 (1), 1-10, 2024 | | 2024 |
| Analysis of Ageism in Radiotherapy Oncology Group F Tramacere, M Borgia, T Proto, A Sallustio, F Pati, M Portaluri, S Parisi, ... Oncol 2 (1), 1014, 2024 | | 2024 |
| PO-1535 Hypofractionated post-operative prostate bed radiotherapy: ten-years outcomes A Castelluccia, F Tramacere, T Proto, A Sallustio, M Portaluri Radiotherapy and Oncology 182, S1246-S1247, 2023 | | 2023 |
| PO-1497 MRgSBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis A D'Aviero, L Boldrini, A Romano, G Chiloiro, S Corradini, V De Luca, ... Radiotherapy and Oncology 182, S1215-S1216, 2023 | | 2023 |
| PO-1519 Stereotactic adaptive MR-guided RT: post-operative RT and re-irradiation for prostate local relapse A Castelluccia, G Grimaldi, D Marchesano, I Annessi, F Bianciardi, ... Radiotherapy and Oncology 182, S1235-S1236, 2023 | | 2023 |
| Stereotactic MR-guided adaptive radiotherapy (SMART) for primary rectal cancer: evaluation of early toxicity and pathological response A Castelluccia, D Marchesano, G Grimaldi, I Annessi, F Bianciardi, ... Reports of Practical Oncology and Radiotherapy 28 (4), 437-444, 2023 | | 2023 |
| PO-1401 MR-guided adaptive versus CT-guided SBRT for prostate cancer: where is cost-benefit balance? A Castelluccia, D Marchesano, G Grimaldi, I Annessi, F Bianciardi, ... Radiotherapy and Oncology 170, S1188-S1189, 2022 | | 2022 |
| Stereotactic MR-guided Adaptive RT for rectal cancer: toxicity, radiological & pathological response A Castelluccia, D Marchesano, G Grimaldi, I Annessi, F Bianciardi, ... RADIOTHERAPY AND ONCOLOGY 170, S443-S444, 2022 | | 2022 |
| PD-0495 Stereotactic MR-guided Adaptive RT for rectal cancer: toxicity, radiological & pathological response A Castelluccia, D Marchesano, G Grimaldi, I Annessi, F Bianciardi, ... Radiotherapy and Oncology 170, S444-S445, 2022 | | 2022 |
